{Reference Type}: Journal Article
{Title}: Management of Regional Nodal Melanoma.
{Author}: Angeles CV;Wong SL;
{Journal}: Surg Oncol Clin N Am
{Volume}: 29
{Issue}: 3
{Year}: Jul 2020
{Factor}: 2.402
{DOI}: 10.1016/j.soc.2020.02.007
{Abstract}: Regional nodal melanoma management has changed substantially over the past 2 decades alongside advances in systemic therapy. Significant data from retrospective studies and from 2 randomized controlled trials show no survival benefit to completion lymph node dissection compared with observation in sentinel lymph node-positive melanoma patients. Observation is becoming the standard recommendation in these patients, whereas patients with clinically detected lymph nodes are still recommended to undergo lymph node dissection. Promising early results from a neoadjuvant approach inform the ongoing evolution of melanoma management. Recruiting patients to clinical trials is paramount to attaining evidence-based practice changes in melanoma.